Interpretable gene networks from single-cell foundation models reveal conserved neurogenic dysfunction in Parkinson's disease
Yin, J.; Gosztyla, M.; Gokbag, B.; Rychkova, A.; Wilkinson, I.; St John, J.; Shah, V.; Nickels, S. L.; Schwamborn, J. C.; Fremeau, R. T.
Show abstract
Interpreting large-scale single-cell transcriptomic data remains a major challenge for understanding disease mechanisms. Recent single-cell foundation models learn rich representations of gene relationships across millions of cells, yet methods for translating these embeddings into biologically interpretable gene networks remain limited. Here we present scGENet, a computational framework that constructs context-specific gene interaction networks from foundation model-derived gene embeddings. By fine-tuning pretrained models on transcriptomic data from human midbrain organoids, scGENet generates transcriptome-scale gene modules that capture biologically meaningful cellular programs. Benchmarking across multiple foundation models demonstrates that networks derived from a fine-tuned scGPT brain model show the highest concordance with curated neuronal pathways, Parkinsons disease (PD) genetic risk loci, and independent patient-derived transcriptional signatures. Applying this framework to human iPSC-derived PD midbrain organoids reveals transcriptional modules associated with neuronal differentiation, synaptic signaling, and cell-cycle regulation. Single-nucleus RNA sequencing further links these programs to altered cellular composition, including reduced dopaminergic neurons, expansion of radial glia-like progenitors, and a dopaminergic neuron subtype expressing SNCA and VGLUT2. Integration with independent human substantia nigra datasets identifies a conserved neurogenic program disrupted across genetic and idiopathic PD. Together, these results establish a generalizable strategy for extracting interpretable gene networks from single-cell foundation models, enabling systematic discovery of disease-relevant molecular programs across diverse tissues and datasets.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts 96%
- A human single-cell atlas of the Substantia nigra reveals novel cell-specific pathways associated with the genetic risk of Parkinson's disease and neuropsychiatric disorders. 96%
- Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease 95%
Similar papers in this journal
- Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease 94%
- Single-cell multiomics identifies both shared and unique features of immune dysfunction in the colon, plasma and stool from individuals diagnosed with Parkinson's disease or inflammatory bowel disease 94%
- Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases 93%
Similar papers in this journal
Similar papers in this journal
- Dedifferentiation and neuronal repression define Familial Alzheimer's Disease 94%
- Phosphoglycerate kinase 1 is a central leverage point in Parkinson's disease driven neuronal metabolic deficits 94%
- Gene Regulatory Network topology governs resistance and treatment escape in glioma stem-like cells 93%
Similar papers in this journal
- Single cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging and disease 96%
- A Mitochondrial Inside-Out Iron-Calcium Signal Reveals Drug Targets for Parkinsons Disease 95%
- ALS molecular subtypes are a combination of cellular, genetic, and pathological features learned by deep multiomics classifiers 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.